Identification of cardiovascular risk by triglyceride/HDL- cholesterol ratio in patients with chronic renal disease in hemodialysis
DOI:
https://doi.org/10.15448/1980-6108.2017.3.27369Keywords:
chronic renal disease, cardiovascular diseases, risk factors, hemodialysis.Abstract
***Identification of cardiovascular risk by triglyceride/HDL- cholesterol ratio in patients with chronic renal disease in hemodialysis***
AIMS: To identify cardiovascular risk by triglyceride/high density lipoprotein cholesterol ratio (TG/HDL-c) and to verify its association with socio-demographic factors, clinical parameters and body mass index in patients with chronic renal disease on hemodialysis.
METHODS: Cross-sectional study, in which patients with chronic kidney disease in hemodialysis were evaluated. A non-probability convenience sampling was used. Sociodemographic data were collected through a semi-structured questionnaire interview, and clinical and laboratory data were obtained from the medical records. For the identification of cardiovascular risk, the TG/HDL-c ratio was calculated from plasma triglycerides (mg/dL) and high density lipoprotein cholesterol (mg/dL). The cut-off point for TG/HDL-c considered to be indicative of cardiovascular risk was ≥3.8 mg/dL. For statistical analysis, the chi-square test was used, and the significance level was set at 5% (p <0.05).
RESULTS: A total of 71 patients were evaluated, with a mean age of 49.9±13.2 years, being 28 women (50.1±13.2 years) and 43 men (49.7±13.2 years). Among the 71 patients, 31 (43.66%) had cardiovascular risk characterized by the TG/HDL-c ratio ≥3.8 mg/dL. In general, the profile of patients with and without cardiovascular risk was similar. However, in patients with cardiovascular risk there was a higher proportion of males (77.42%), while in those who did not have this risk, the female gender was more frequent (52.50%). This variable showed a significant difference between the groups with and without cardiovascular risk (p=0.011).
CONCLUSIONS: In this sample of patients with chronic kidney disease on hemodialysis, the TG/HDL-c ratio identified a high cardiovascular risk index, which was significantly associated with males.
Downloads
References
Madeiro AC, Machado PD, Bonfim IM, Braqueais AR, Lima FE. Adherence of chronic renal insufficiency patients to hemodialysis. Acta Paul Enferm. 2010; 23(4):546-51. https://doi.org/10.1590/S0103-21002010000400016
Cuppari L, Avesani CA, Kamimura MA. Nutrição na doença renal crônica. 1ª ed. Barueri, SP: Manole; 2013.
Hage FG, Venkataraman R, Zoghbi GJ, Perry GJ, Mattos AM, Iskandrian AE. The scope of coronary heart disease in patients with chronic kidney disease. J Am Coll Cardiol. 2009;53(23):2129-40. https://doi.org/10.1016/j.jacc.2009.02.047
Barberato SH, Pecoits-Filho R. Alterações ecocardiográficas em pacientes com insuficiência renal crônica em programa de hemodiálise. Arq Bras Cardiol. 2010;94(1):140-6. https://doi.org/10.1590/S0066-782X2010000100021
Bakris GL. Recognition, pathogenesis, and treatment of different stages of nephropathy in patients with type 2 diabetes mellitus. Mayo Clin Proc. 2011;86(5):444-56. https://doi.org/10.4065/mcp.2010.0713
Vieira JM, Suassuna JHR. O acometimento renal na hipertensão arterial e diabetes mellitus tipo 2: como identificar e prevenir? A visão do nefrologista. Revista HUPE, Rio de Janeiro. 2013;12(suppl.1):53-60. https://doi.org/10.12957/rhupe.2013.7083
Lekawanvijit S, Kompa AR, Wang BH, Kelly DJ, Krum H. Cardiorenal syndrome: the emerging role of protein-bound uremic toxins. Circ Res. 2012;111(11):1470-83. https://doi.org/10.1161/CIRCRESAHA.112.278457
Tumlin JA, Costanzo MR, Chawla LS, Herzog CA, Kellum JA, McCullough PA, et al. Cardiorenal syndrome type 4: insights on clinical presentation and pathophysiology from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol. 2013;182:158-73. https://doi.org/10.1159/000349972
Bucharles SGE, Varela AM, Barberato SH, Pecoits-Filho R. Avaliação e manejo da doença cardiovascular em pacientes com doença renal crônica. J Bras Nefrol. 2010;32(1):120-7. https://doi.org/10.1590/S0101-28002010000100019
Nihi MM, Manfro RC, Martins C, Suliman M, Murayama Y, Riella MC, Bengt Lindholm B, do Nascimento MM. Associação entre gordura corporal, inflamação e estresse oxidativo na hemodiálise. J Bras Nefrol. 2010;32(1):11-7. https://doi.org/10.1590/S0101-28002010000100003
Silva ARA, Dourado KF, Pereira PB, Lima DSC, Fernandes AO, Andrade AM, Henriques MAM. Razão TG/HDL-C e Indicadores antropométricos preditores de risco para doença cardiovascular. Rev Bras Cardiol. 2012;25(1):41-9.
Reis NSC, Alencar JD, Hortegal E, Dias RSC, Calado IL. Risco cardiovascular em pacientes em tratamento hemodialítico: parâmetros antropométricos e razão triglicerídeo/HDL-colesterol. Rev Pesq Saúde. 2015;16(3):170-4.
Krause MP, Hallage T, Miculis CP, Gama MPR, Silva SG. Análise do perfil lipídico de mulheres idosas em Curitiba-Paraná. Arq Bras Cardiol. 2008;90(5):327-32. https://doi.org/10.1590/S0066-782X2008000500004
Andrade MIS, Dourado KF, De Lima CR, De Orange LG, Bento RA, Rodrigues DAS, et al. Razão Triglicerídeo/HDL-C como indicador de risco cardiovascular em alcoolistas crônicos. Rev Bras Cardiol. 2012;25(4):267-75.
Vieira EA, Carvalho WA, Aras Júnior R, Couto FD, Couto RD. Razão triglicérides/HDL-c e proteína C reativa de alta sensibilidade na avaliação do risco cardiovascular. J. Bras. Patol. Med. Lab. 2011;47(2):113-8. https://doi.org/10.1590/S1676- 24442011000200004
Daugirdas JT. Second generation logarithmic estimates or single pool variable volume kt/V: an analysis of error. J Am Soc Nephrol. 1993;4(5):1205-13.
Martins C, Cardoso SP. Terapia nutricional enteral e parenteral – Manual de rotina técnica. Curitiba: Nutroclínica; 2000. 445 p.
World Health Organization. WHO Technical Report Series, 854. Physical status: the use and interpretation of anthropometry. Geneva: World Health Organization;1995.
Lipschitz DA. Screening for nutritional status in the elderly. Prim Care. 1994;21(1):55-67.
Hanak V, Munoz J, Teague J, Stanley Junior A, Bittner V. Accuracy of the triglyceride to high-density lipoprotein cholesterol ratio for prediction of the low-density lipoprotein phenotype B. Am J Cardiol. 2004;94(2):219-22. https://doi.org/10.1016/j.amjcard.2004.03.069
Leavey SF, Strawderman RI, Jones CA, Port FK, Held PJ. Simple nutritional indicators as independente predictors of mortality in hemodialysis patients. Am J Kidney Dis. 1998;31(6):997-1006. https://doi.org/10.1053/ajkd.1998.v31.pm9631845
National Kidney Foundation. K/DOQI. Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients. Am J Kidney Dis. 2005;45(Suppl 3):S1-154.
Sarnak MJ, Levey AS. Epidemiology, diagnosis, and management of cardiac disease in chronic renal disease. J Thromb Thrombolysis. 2000;10(2):169-80. https://doi.org/10.1023/A:1018718727634
Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HL, Mann JF et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013;382:339-52. https://doi.org/10.1016/S0140-6736(13)60595-4
Burmeister JE, Mosmann CB, Costa VB, Saraiva RT, Grandi RR, Bastos JP, Gonçalves LS, Rosito GA. Prevalência de fatores de risco cardiovascular em pacientes em hemodiálise – O Estudo CORDIAL. Arq Bras Cardiol. 2014;102(5):473-80. http://dx.doi.org/10.5935/abc.20140048
Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL. Kidney Disease as a Risk Factor for Development of Cardiovascular Disease. Hypertension. 2003;42:1050-65. https://doi.org/10.1161/01.HYP.0000102971.85504.7c
Tonelli M, Karumanchi SA, Thadhani R. Epidemiology and Mechanisms of Uremia-Related Cardiovascular Disease. Circulation. 2016;133:518-36. https://doi.org/10.1161/CIRCULATIONAHA.115.018713
Gaziano JM, Hennekens CH, O'Donnell CJ, Breslow JL, Buring JE. Fasting triglycerides, high density lipoprotein, and risk of myocardial infarction. Circulation. 1997;96(8):2520-5. https://doi.org/10.1161/01.CIR.96.8.2520
Jeppesen J, Hein HO, Suadicani P, Gyntelberg F. Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study. Circulation. 1998;97(11):1029-36. https://doi.org/10.1161/01.CIR.97.11.1029
Luz PL, Favarato D, Faria-Neto Junior JR; Lemos P, Chagas ACP. High ratio of triglycerides to HDL cholesterol predicts extensive coronary disease. Clinics São Paulo. 2008;63(4):427-32. https://doi.org/10.1590/S1807-59322008000400003
Cullen P. Evidence that triglycerides are an independent coronary heart disease risk factor. Am J Cardiol. 2000;86(9):943-9. https://doi.org/10.1016/S0002-9149(00)01127-9
Oliveira HMJ, Formiga FFC, Alexandre CS. Perfil clínico-epidemiológico dos pacientes em programa crônico de hemodiálise em João Pessoa - PB. J Bras Nefrol. 2014;36(3):367-74.
Telles CT, Dobner T, Pomatti G, Fortes VF, Brock F, Bettinelli LA. Perfil sociodemgráfico, clínico e laboratorial de pacientes submetidos à hemodiálise. Rev Rene. 2014;15(3):420-6. https://doi.org/10.15253/2175-6783.2014000300006
Oliveira CS, Silva EC, Ferreira LW, Skalinski LM. Perfil dos pacientes renais crônicos em tratamento hemodialítico. Rev. Baiana Enferm. 2015;29(1):42-9.
Mello MVFA, Menezes KSP, Pires KKC, Angelo M. Panorama da doença renal terminal em um estado da Amazônia brasileira. Rev Min Enferm. 2017;21:e-994.
Sakurai M, Kobayashi J, Takeda Y, Nagasawa S-Y, Yamakawa J, Moriya J, Mabuchi H, Nakagawa H. J Epidemiol. 2016;26(8):440-6. https://doi.org/10.2188/jea.JE20150208
Margaret KY, Katon W, Young BA. Associations between sex and incident chronic kidney disease in a prospective diabetic cohort. Nephrology. 2015;20:451-8. https://doi.org/10.1111/nep.12468
Valenzuela RGV, Giffoni AG, Cuppari L, Canziani MEF. Estado nutricional de pacientes com insuficiência renal crônica em hemodiálise no Amazonas. Rev Assoc Med. Bras. 2003;49(1):72-8. https://doi.org/10.1590/S0104-42302003000100037
Kusumoto L, Marques S, Haas VJ, Rodrigues RAP. Adultos e idosos em hemodiálise: avaliação da qualidade de vida relacionada à saúde. Acta Paul Enferm. 2008;21:152-9. https://doi.org/10.1590/S0103-21002008000500003
Legg V. Complications of chronic kidney disease. AJN. 2005;105:40-9. https://doi.org/10.1097/00000446-200506000-00024
Kusumoto L, Marques S, Haas VJ, Rodrigues RAP. Adultos e idosos em hemodiálise: avaliação da qualidade de vida relacionada à saúde. Acta Paul Enferm. 2008;21:152-9. https://doi.org/10.1590/S0103-21002008000500003
Bonotto GM, Mendoza-Sassi RA, Susin LRO. Conhecimento dos fatores de risco modificáveis para doença cardiovascular entre mulheres e seus fatores associados: um estudo de base populacional. Cien Saude Colet. 2016;21(1):293-302. https://doi.org/10.1590/1413- 81232015211.07232015
Chor D. Saúde pública e mudanças de comportamento: uma questão contemporânea. Cad. Saúde Pública, Rio de Janeiro. 1999;15(2):423-5.
Al-Thani H, Shabana A, Hussein A, Sadek A, Sharaf A, Koshy V et al. Cardiovascular Complications in Diabetic Patients Undergoing Regular Hemodialysis: A 5-Year Observational Study. Angiology. 2015;66(3):225-30. https://doi.org/10.1177/0003319714523672
Rudnicki T. Preditores de qualidade de vida em pacientes renais crônicos. Estud. Psicol. (Campinas). 2007;24:343-51. https://doi.org/10.1590/S0103-166X2007000300006
Downloads
Published
How to Cite
Issue
Section
License
Copyright
The submission of originals to Scientia Medica implies the transfer by the authors of the right for publication. Authors retain copyright and grant the journal right of first publication. If the authors wish to include the same data into another publication, they must cite Scientia Medica as the site of original publication.
Creative Commons License
Except where otherwise specified, material published in this journal is licensed under a Creative Commons Attribution 4.0 International license, which allows unrestricted use, distribution and reproduction in any medium, provided the original publication is correctly cited.
